MedTrace Logo

The Influence of Combined Oral Contraception on the DEvelopment and progRession of Chronic venoUs diSeases

NCT04451746 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 116

Last updated 2026-03-05

No results posted yet for this study

Summary

Investigation of the influence of combined oral contraception on the development and progression of chronic venous diseases

Conditions

  • Chronic Venous Diseases

Interventions

DRUG

Combined Oral Contraceptive

The investigators consistently include patients who have been prescribed hormonal tablets for contraception, namely 1) COCs with bioidentical estrogen; 2) COCs with ethinyl estradiol 30mkg according to the scheme 21 + 7; 3) COCs with ethinyl estradiol 20mkg according to the scheme 21 + 7.

Sponsors & Collaborators

  • Clinic of Phlebology and Laser Surgery, Chelyabinsk, Russia

    lead OTHER

Principal Investigators

  • Alexey Fokin · South Ural State Medical University

Study Design

Allocation
NA
Purpose
SCREENING
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-24
Primary Completion
2026-02-23
Completion
2026-02-23

Countries

  • Russia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04451746 on ClinicalTrials.gov